desoximetasone NDC 63629-8641

NDC codes

FDA NDC Directory

Product NDC (as listed)63629-8641Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63629-8641Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63629-8641-1	63629864101	1 TUBE in 1 CARTON (63629-8641-1) / 15 g in 1 TUBEMarketed from May 14, 2015

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): desoximetasone
Generic name (nonproprietary): desoximetasone
Active ingredients: Desoximetasone — 2.5 mg/g
Dosage form: Ointment
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 077770
Marketing start: May 14, 2015
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 63629-8641_00b6c089-dcbd-9278-e063-6394a90ab774SPL ID 00b6c089-dcbd-9278-e063-6394a90ab774SPL set ID dbaa172e-2f78-4c14-9abc-cc171b75115dRxCUI 197575UNII 4E07GXB7AU
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463629864101 followed by a unit qualifier and the quantity

Package 63629-8641-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 17, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Desoximetasone Ointment USP, 0.25% is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 077770

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 077770
Product	Strength	Form · route	Labeler	Product NDC
desoximetasone	Desoximetasone 2.5 mg/g	OintmentTopical	Padagis Israel Pharmaceuticals Ltd	45802-496
desoximetasone	Desoximetasone 2.5 mg/g	OintmentTopical	Bryant Ranch Prepack	72162-1414
desoximetasone	Desoximetasone 2.5 mg/g	OintmentTopical	Bryant Ranch Prepack	63629-8642